VC: Javelin, Sensors for Medicine and Science, Alchemia raise funds
Javelin Pharmaceuticals has raised $32 million in financing, with NGN Capital as the lead investor. The company has two drugs in development and one currently in the regulatory filing process.
- read this press release for more
ALSO: Sensors for Medicine and Science has landed an additional $15 million in financing, part of a $30 million third round. The money will be used to develop the biotech's glucose monitoring system for diabetics. Article
PLUS: Australian drug company Alchemia announced yesterday that it has raised $14.6 million, which it will use to finance its product pipeline. Release
Comments